Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic
We’ll send you a myFT Daily Digest email rounding up the latest FT News Briefing news every morning.
Donald Trump and Joe Biden clash over issues from the pandemic to foreign policy
Donald Trump and his Democratic challenger, Joe Biden, clashed over issues from the pandemic to foreign policy in their final presidential election debate. Then, the FT’s Demetri Sevastopulo will explain why local races in Texas and around the US could dictate the political make-up of the country for years to come. Plus, Gilead has received the first US regulatory approval for a Covid-19 drug, and Intel reported a decline in data centre revenues and said its earnings fell by nearly a quarter from a year ago due to the pandemic.
Donald Trump and Joe Biden clash over coronavirus in final debate
Gilead secures FDA approval for remdesivir
See acast.com/privacy for privacy and opt-out information.
Transcripts are not currently available for all podcasts, view our accessibility guide.
Get alerts on FT News Briefing when a new story is published